ALEXION PHARMACEUTICALS, INC. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 188.07 | 15,952 | 3,000,093 | 949,426 | 965.4 K to 949.4 K (-1.65 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 180.34 | 6,565 | 1,183,932 | 22,090 | 28.7 K to 22.1 K (-22.91 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Buy | S | 0.00 | 5,100 | 0 | 28,655 | 23.6 K to 28.7 K (+21.65 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 180.34 | 487 | 87,826 | 167,321 | 167.8 K to 167.3 K (-0.29 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 5,100 | 0 | 167,808 | 162.7 K to 167.8 K (+3.13 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 180.34 | 370 | 66,726 | 36,949 | 37.3 K to 36.9 K (-0.99 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 5,100 | 0 | 37,319 | 32.2 K to 37.3 K (+15.83 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,830 | 0 | 6,830 | 3 K to 6.8 K (+127.67 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 180.37 | 5,874 | 1,059,493 | 5,874 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 180.34 | 280 | 50,495 | 33,342 | 33.6 K to 33.3 K (-0.83 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 1,745 | 0 | 33,622 | 31.9 K to 33.6 K (+5.47 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 5,100 | 0 | 31,877 | 26.8 K to 31.9 K (+19.05 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | SVP, EMEA & Asia Pa ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Thiel Carsten | SVP, EMEA & Asia Pa ... | Grant | A | 0.00 | 3,830 | 0 | 29,830 | 26 K to 29.8 K (+14.73 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 180.34 | 228 | 41,118 | 39,432 | 39.7 K to 39.4 K (-0.57 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Grant | A | 0.00 | 5,100 | 0 | 39,660 | 34.6 K to 39.7 K (+14.76 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Option Exercise | A | 180.37 | 18,300 | 3,300,771 | 18,300 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Grant | A | 0.00 | 3,830 | 0 | 9,043 | 5.2 K to 9 K (+73.47 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Option Exercise | A | 180.37 | 5,874 | 1,059,493 | 5,874 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 180.34 | 706 | 127,320 | 27,809 | 28.5 K to 27.8 K (-2.48 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Grant | A | 0.00 | 1,745 | 0 | 28,515 | 26.8 K to 28.5 K (+6.52 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Grant | A | 0.00 | 5,100 | 0 | 26,770 | 21.7 K to 26.8 K (+23.53 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 7,626 | 1,375,502 | 7,626 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 32,200 | 5,807,914 | 32,200 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 180.34 | 730 | 131,648 | 132,858 | 133.6 K to 132.9 K (-0.55 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 2,265 | 0 | 133,588 | 131.3 K to 133.6 K (+1.72 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 7,290 | 0 | 131,323 | 124 K to 131.3 K (+5.88 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | A | 180.37 | 98,200 | 17,712,334 | 98,200 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 180.34 | 1,230 | 221,818 | 965,378 | 966.6 K to 965.4 K (-0.13 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 22,300 | 0 | 966,608 | 944.3 K to 966.6 K (+2.36 %) |